EXPRES2ION BIOTECH HLDG
ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2ion Biotechnologies ApS, researches and develops preventive and therapeutic vaccine products in the Nordics and internationally. The company's lead asset is ES2B-C001, a therapeutic vaccine for breast cancer that targets the human epidermal growth factor receptor 2 receptor. It is also developing ES2B-I002, a cytomegalovirus vac… Read more
Market Cap & Net Worth: EXPRES2ION BIOTECH HLDG (5JD)
EXPRES2ION BIOTECH HLDG (F:5JD) has a market capitalization of $3.37 Million (€3.28 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #40147 globally and #5827 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EXPRES2ION BIOTECH HLDG's stock price €1.56 by its total outstanding shares 2100280 (2.10 Million).
EXPRES2ION BIOTECH HLDG Market Cap History: 2020 to 2024
EXPRES2ION BIOTECH HLDG's market capitalization history from 2020 to 2024. Data shows change from $83.44 Million to $3.37 Million (-58.76% CAGR).
EXPRES2ION BIOTECH HLDG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EXPRES2ION BIOTECH HLDG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 5JD by Market Capitalization
Companies near EXPRES2ION BIOTECH HLDG in the global market cap rankings as of March 18, 2026.
Key companies related to EXPRES2ION BIOTECH HLDG by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
EXPRES2ION BIOTECH HLDG Historical Marketcap From 2020 to 2024
Between 2020 and today, EXPRES2ION BIOTECH HLDG's market cap moved from $83.44 Million to $ 3.37 Million, with a yearly change of -58.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | €3.37 Million | -76.80% |
| 2023 | €14.53 Million | -87.89% |
| 2022 | €119.99 Million | -57.24% |
| 2021 | €280.62 Million | +236.30% |
| 2020 | €83.44 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 27th, 2025 the market cap of EXPRES2ION BIOTECH HLDG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.37 Million USD |
| MoneyControl | $3.37 Million USD |
| MarketWatch | $3.37 Million USD |
| marketcap.company | $3.37 Million USD |
| Reuters | $3.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.